A

AbbVie Inc.

ABBV Stocks
$286.74+0.39%24h
24h Range
$285.18$289.59

Volume Bubbles Chart (1h)

Each 1-hour candle's volume is signed by its direction (up candles count as net buying, down candles as net selling) and drawn as a bubble at the closing price, green for buying and red for selling. Bubble size and colour intensity show how strong that flow is compared with the last 300 candles: the strongest 30% get full bubbles with their USD value, the rest stay as small dots. Unusually large bubbles flag aggressive buying or selling worth a closer look, often near breakouts, reversals or key levels.

Seasonal Chart

Plots one line per calendar year showing the % change since the start of that year, with the current year highlighted against up to four previous years. Lining the years up on the same calendar shows whether the price tends to rise or fall in the same months, helping you spot recurring seasonal patterns. Treat it as context rather than a forecast: past seasonality does not guarantee future moves.

AbbVie Inc. Historical Data

About AbbVie Inc.

AbbVie is a biopharmaceutical company that researches, develops, and markets medicines across therapeutic areas including immunology, oncology, neuroscience, and aesthetics. The company was spun off from Abbott Laboratories in 2013.

AbbVie became widely known for Humira, one of the best-selling prescription drugs in history, and has worked to diversify its portfolio as Humira faces increased competition from lower-cost biosimilar alternatives following patent expiration.

AbbVie Inc. (ABBV) FAQ

What kind of company is AbbVie?

AbbVie is a biopharmaceutical company focused on immunology, oncology, neuroscience, and aesthetics treatments.

What is AbbVie best known for?

AbbVie is widely known for Humira, an immunology drug that was historically one of the best-selling prescription medicines in the world.

How is AbbVie related to Abbott Laboratories?

AbbVie was spun off from Abbott Laboratories in 2013 to separate Abbott's research-based pharmaceutical business from its diversified medical products business.

Does AbbVie make Botox?

Yes, through its acquisition of Allergan, AbbVie's portfolio includes Botox and other aesthetics and eye care products.

Why do biosimilars matter for AbbVie?

As Humira's patent protection has expired in various markets, lower-cost biosimilar versions have entered, creating competitive pressure that AbbVie has worked to offset with newer drugs.

Where can I view live AbbVie charts?

You can view a live, interactive ABBV chart above, or open it in the full multi-chart grid using the button on this page.